Human Genome Epidemiology Literature Finder
|
Records 1 - 23 (of 23 Records) |
| Query Trace: Myelodysplastic Syndromes and IDH1[original query] |
|---|
| Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC cancer 2010 10 (1): 401. Rocquain Julien, Carbuccia Nadine, Trouplin Virginie, Raynaud Stéphane, Murati Anne, Nezri Meyer, Tadrist Zoulika, Olschwang Sylviane, Vey Norbert, Birnbaum Daniel, Gelsi-Boyer Véronique, Mozziconacci Marie-Joel |
| IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. Haematologica 2010 Oct 95 (10): 1668-74. Thol Felicitas, Weissinger Eva M, Krauter Jürgen, Wagner Katharina, Damm Frederik, Wichmann Martin, Göhring Gudrun, Schumann Christiane, Bug Gesine, Ottmann Oliver, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
| Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia 2010 May 24 (5): 1094-6. Kosmider O, Gelsi-Boyer V, Slama L, Dreyfus F, Beyne-Rauzy O, Quesnel B, Hunault-Berger M, Slama B, Vey N, Lacombe C, Solary E, Birnbaum D, Bernard O A, Fontenay |
| A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders. Leukemia 2011 Jan 25 (1): 184-6. Yoshida K, Sanada M, Kato M, Kawahata R, Matsubara A, Takita J, Shih L-Y, Mori H, Koeffler H P, Ogawa |
| IDH1 and IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia but rare in other types of hematological disorders. Biochemical and biophysical research communications 2010 Nov 402 (2): 378-83. Zou Yang, Zeng Yun, Zhang Deng-Feng, Zou Shan-Hua, Cheng Yun-Feng, Yao Yong-Ga |
| ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. British journal of haematology 2010 Nov 151 (4): 365-75. Gelsi-Boyer Véronique, Trouplin Virginie, Roquain Julien, Adélaïde José, Carbuccia Nadine, Esterni Benjamin, Finetti Pascal, Murati Anne, Arnoulet Christine, Zerazhi Hacène, Fezoui Hacène, Tadrist Zoulika, Nezri Meyer, Chaffanet Max, Mozziconacci Marie-Joëlle, Vey Norbert, Birnbaum Dani |
| Differential prognostic effect of IDH1 versus IDH2 mutations in myelodysplastic syndromes: a Mayo Clinic study of 277 patients. Leukemia 2012 Jan 26 (1): 101-5. Patnaik M M, Hanson C A, Hodnefield J M, Lasho T L, Finke C M, Knudson R A, Ketterling R P, Pardanani A, Tefferi |
| Mutation analysis of isocitrate dehydrogenase in acute lymphoblastic leukemia. Genetic testing and molecular biomarkers 2012 Aug 16 (8): 991-5. Zhang Yiqun, Wei Hui, Tang Kejing, Lin Dong, Zhang Cuiping, Mi Yingchang, Wang Lin, Wang Cuicui, Wang Min, Wang Jianxia |
| Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012 Apr 119 (15): 3578-84. Thol Felicitas, Kade Sofia, Schlarmann Carola, Löffeld Patrick, Morgan Michael, Krauter Jürgen, Wlodarski Marcin W, Kölking Britta, Wichmann Martin, Görlich Kerstin, Göhring Gudrun, Bug Gesine, Ottmann Oliver, Niemeyer Charlotte M, Hofmann Wolf-Karsten, Schlegelberger Brigitte, Ganser Arnold, Heuser Micha |
| Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations. Haematologica 2014 Jan 99 (1): 28-36. Lin Tung-Liang, Nagata Yasunobu, Kao Hsiao-Wen, Sanada Masashi, Okuno Yusuke, Huang Chein-Fuang, Liang Der-Cherng, Kuo Ming-Chung, Lai Chang-Liang, Lee En-Hui, Shih Yu-Shu, Tanaka Hiroko, Shiraishi Yuichi, Chiba Kenichi, Lin Tung-Huei, Wu Jin-Hou, Miyano Satoru, Ogawa Seishi, Shih Lee-Yu |
| Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia 2014 Jan 28 (1): 78-87. Traina F, Visconte V, Elson P, Tabarroki A, Jankowska A M, Hasrouni E, Sugimoto Y, Szpurka H, Makishima H, O'Keefe C L, Sekeres M A, Advani A S, Kalaycio M, Copelan E A, Saunthararajah Y, Olalla Saad S T, Maciejewski J P, Tiu R |
| Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia. Haematologica 2013 Jan . Shih AH, Chung SS, Dolezal EK, Zhang SJ, Abdel-Wahab OI, Park CY, Nimer SD, Levine RL, Klimek VM |
| Prognostic value of isocitrate dehydrogenase mutations in myelodysplastic syndromes: a retrospective cohort study and meta-analysis. PloS one 2014 9 (6): e100206. Jin Jie, Hu Chao, Yu Mengxia, Chen Feifei, Ye Li, Yin Xiufeng, Zhuang Zhengping, Tong Hongy |
| The Frequency and clinical significance of IDH1 mutations in Chinese acute myeloid leukemia patients. PloS one 2013 8 (12): e83334. Guan Lixun, Gao Li, Wang Lili, Li Meng, Yin Yue, Yu Li, Gao Chun |
| Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes. The Journal of molecular diagnostics : JMD 2015 Aug . Platt Mia Y, Fathi Amir T, Borger Darrell R, Brunner Andrew M, Hasserjian Robert P, Balaj Leonora, Lum Amy, Yip Stephen, Dias-Santagata Dora, Zheng Zongli, Le Long P, Graubert Timothy A, Iafrate A John, Nardi Valenti |
| IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes. Acta haematologica 2017 Sep 138 (3): 143-151. Wang Na, Wang Fei, Shan Ningning, Sui Xiaohui, Xu Hongz |
| Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes. Journal of cancer research and clinical oncology 2018 Mar . Lin Peipei, Luo Yingwan, Zhu Shuanghong, Maggio Dominic, Yang Haiyang, Hu Chao, Wang Jinghan, Zhang Hua, Ren Yanling, Zhou Xinping, Mei Chen, Ma Liya, Xu Weilai, Ye Li, Zhuang Zhengping, Jin Jie, Tong Hongy |
| Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome. Journal of clinical pathology 2019 11 73 (4): 209-212. Badaat Ibraahim, Mirza Sabbir, Padron Eric, Sallman David, Komrokji Rami, Song Jinming, Hussaini Mohammad |
| Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation. Hematology (Amsterdam, Netherlands) 2020 6 25 (1): 211-218. Wang Kai, Zhou Feng, Cai Xiaohui, Chao Hongying, Zhang Ri, Chen Suni |
| Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms. Leukemia 2020 12 35 (8): 2371-2381. Todisco Gabriele, Creignou Maria, Gallì Anna, Guglielmelli Paola, Rumi Elisa, Roncador Marco, Rizzo Ettore, Nannya Yasuhito, Pietra Daniela, Elena Chiara, Bono Elisa, Molteni Elisabetta, Rosti Vittorio, Catricalá Silvia, Sarchi Martina, Dimitriou Marios, Ungerstedt Johanna, Vannucchi Alessandro Maria, Hellström-Lindberg Eva, Ogawa Seishi, Cazzola Mario, Malcovati Lu |
| Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study. Leukemia & lymphoma 2020 10 62 (2): 438-445. Willekens C, Rahme R, Duchmann M, Vidal V, Saada V, Broutin S, Delahousse J, Renneville A, Marceau A, Clappier E, Uzunov M, Rossignol J, Pascal L, Simon L, Micol J B, Pasquier F, Raffoux E, Preudhomme C, Quivoron C, Itzykson R, Penard-Lacronique V, Paci A, Fenaux P, Attar E C, Frattini M, Braun T, Ades L, De Botton |
| Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer medicine 2021 Feb . Yan Xuefen, Wang Lu, Jiang Lingxu, Luo Yingwan, Lin Peipei, Yang Wenli, Ren Yanling, Ma Liya, Zhou Xinping, Mei Chen, Ye Li, Xu Gaixiang, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes. Hematology (Amsterdam, Netherlands) 2023 2 28 (1): 2180704. Papadopoulou Vasiliki, Schoumans Jacqueline, Basset Valentin, Solly Françoise, Pasquier Jérôme, Blum Sabine, Spertini Olivi |
- Page last reviewed:Feb 1, 2024
- Content source: